Adamantinoma And Ameloblastoma: Histologic Homologues

Bhagavath, Prashantha (2014) Adamantinoma And Ameloblastoma: Histologic Homologues. Journal of Evolution of Medical and Dental Sciences, 3 (39). pp. 9864-9869. ISSN 2278-4802

[img] PDF
prashantha_bhagavath_1.pdf - Published Version
Restricted to Registered users only

Download (373kB) | Request a copy


Ameloblastomas are locally aggressive jaw tumors. This research has been undertaken to study the histo-pathological patterns of ameloblastoma and to correlate histopathologic findings with the incidence of recurrence and to present a rare case of Adamantinoma of the tibia and analyze its morphologic resemblance to ameloblastoma. We reviewed 15 cases of ameloblastoma and one case of Adamantinoma of the tibia received in the department of Pathology, Kasturba Medical College, Mangalore between 1976 and 2004. The patients with ameloblastoma included 7 males and 8 females with an age range of 6 years to 66 years. Eleven cases were located in the mandible and 4 cases involved the maxillary sinus of which one presented as a nasal polyp. The most common histologic patterns were follicular and plexiform. Four cases which had been treated conservatively recurred after 6 months to 6 years. Adamantinoma was characterized histologically by nests of basaloid epithelial cells in a fibro osseous stroma. Ameloblastomas are more common in the mandible and conservative therapy is associated with a high rate of recurrence. The most common histologic pattern as well as the most common pattern seen in recurrent cases was the follicular ameloblastoma. Adamantinoma of the tibia is a rare and distinct entity. We recommend that pathologists use the term ameloblastoma when referring to tumours arising from odontogenic epithelium.

Item Type: Article
Uncontrolled Keywords: Adamantinoma; Ameloblastoma; Mandible; Tibia.
Subjects: Medicine > KMC Manipal > Forensic Medicine
Depositing User: KMC Manipal
Date Deposited: 06 Jan 2015 04:21
Last Modified: 06 Jan 2015 04:21

Actions (login required)

View Item View Item